These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23482607)

  • 1. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer.
    Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
    Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
    Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation profiles of endometrioid and serous endometrial cancers.
    Seeber LM; Zweemer RP; Marchionni L; Massuger LF; Smit VT; van Baal WM; Verheijen RH; van Diest PJ
    Endocr Relat Cancer; 2010 Sep; 17(3):663-73. PubMed ID: 20488783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
    He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
    Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma.
    Yang Y; Zhou L; Lu L; Wang L; Li X; Jiang P; Chan LK; Zhang T; Yu J; Kwong J; Cheung TH; Chung T; Mak K; Sun H; Wang H
    Oncogene; 2013 Jul; 32(29):3432-42. PubMed ID: 22907428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of orexin receptors 1 (OX1R) and 2 (OX2R) in the porcine ovary during the oestrous cycle.
    Nitkiewicz A; Smolinska N; Przala J; Kaminski T
    Regul Pept; 2010 Dec; 165(2-3):186-90. PubMed ID: 20688107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression and protein distribution of orexins and orexin receptors in rat retina.
    Liu F; Xu GZ; Wang L; Jiang SX; Yang XL; Zhong YM
    Neuroscience; 2011 Aug; 189():146-55. PubMed ID: 21621592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.
    Su N; Qiu H; Chen Y; Yang T; Yan Q; Wan X
    Oncol Rep; 2013 Jun; 29(6):2297-302. PubMed ID: 23589079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of orexin receptors 1 (OX1R) and 2 (OX2R) in the porcine pituitary during the oestrous cycle.
    Kaminski T; Smolinska N; Nitkiewicz A; Przala J
    Anim Reprod Sci; 2010 Jan; 117(1-2):111-8. PubMed ID: 19394166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer.
    Gottwald L; Pasz-Walczak G; Piekarski J; Szwalski J; Kubiak R; Spych M; Suzin J; Tyliński W; Sęk P; Jeziorski A
    J Obstet Gynaecol; 2014 May; 34(4):346-9. PubMed ID: 24649804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.
    Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V
    Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel wnt regulatory axis in endometrioid endometrial cancer.
    Zhao Y; Yang Y; Trovik J; Sun K; Zhou L; Jiang P; Lau TS; Hoivik EA; Salvesen HB; Sun H; Wang H
    Cancer Res; 2014 Sep; 74(18):5103-17. PubMed ID: 25085246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.